|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.662
|
Human |
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.655
|
Human |
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.647
|
Human |
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.588
|
Human |
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.513
|
Human |
|
mitochondrial atp synthesis coupled electron transport
|
GO:0042775 |
8 |
0.459
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.451
|
Human |
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.432
|
Human |
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.431
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.428
|
Human |
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.409
|
Human |
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.408
|
Human |
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.407
|
Human |
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.390
|
Human |
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.356
|
Human |
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.310
|
Human |
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.279
|
Human |
|
atp metabolic process
|
GO:0046034 |
49 |
0.276
|
Human |
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.260
|
Human |
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.255
|
Human |
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.240
|
Human |
|
larval development
|
GO:0002164 |
104 |
0.239
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.238
|
Human |
|
endocytosis
|
GO:0006897 |
310 |
0.236
|
|
|
oxidative phosphorylation
|
GO:0006119 |
9 |
0.232
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.224
|
Human |
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.216
|
Human |
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.204
|
Human |
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.195
|
Human |
|
determination of adult lifespan
|
GO:0008340 |
137 |
0.193
|
|
|
electron transport chain
|
GO:0022900 |
14 |
0.176
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.169
|
Human |
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.161
|
Human |
|
cellular respiration
|
GO:0045333 |
26 |
0.133
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.128
|
Human |
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.118
|
Human |
|
lipid storage
|
GO:0019915 |
38 |
0.114
|
|
|
multicellular organismal aging
|
GO:0010259 |
140 |
0.113
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.113
|
Human |
|
phosphorylation
|
GO:0016310 |
294 |
0.109
|
|
|
aging
|
GO:0007568 |
143 |
0.093
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.092
|
Human |
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.091
|
|
|
respiratory electron transport chain
|
GO:0022904 |
11 |
0.091
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.090
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.087
|
Human |
|
purine ribonucleoside monophosphate biosynthetic process
|
GO:0009168 |
3 |
0.087
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.087
|
|
|
purine nucleoside biosynthetic process
|
GO:0042451 |
3 |
0.083
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.082
|
Human |
|
stem cell proliferation
|
GO:0072089 |
88 |
0.076
|
|
|
oxidation reduction process
|
GO:0055114 |
123 |
0.073
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.072
|
Human |
|
ion transport
|
GO:0006811 |
145 |
0.071
|
|
|
atp synthesis coupled electron transport
|
GO:0042773 |
8 |
0.068
|
|
|
brain development
|
GO:0007420 |
120 |
0.067
|
Human |
|
ion transmembrane transport
|
GO:0034220 |
122 |
0.067
|
|
|
male gamete generation
|
GO:0048232 |
201 |
0.066
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.064
|
Human |
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.060
|
Human |
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
32 |
0.060
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
42 |
0.057
|
|
|
spermatogenesis
|
GO:0007283 |
200 |
0.056
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.055
|
Human |
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.053
|
Human |
|
cell proliferation
|
GO:0008283 |
299 |
0.052
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.052
|
Human |
|
monovalent inorganic cation transport
|
GO:0015672 |
40 |
0.052
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.051
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.050
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.050
|
Human |
|
organic acid metabolic process
|
GO:0006082 |
103 |
0.049
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.047
|
Human |
|
purine nucleoside triphosphate biosynthetic process
|
GO:0009145 |
2 |
0.047
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.046
|
Human |
|
lipid localization
|
GO:0010876 |
54 |
0.046
|
|
|
growth
|
GO:0040007 |
359 |
0.045
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.043
|
|
|
death
|
GO:0016265 |
284 |
0.042
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.042
|
Human |
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.041
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.041
|
Human |
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.041
|
Human |
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.041
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
30 |
0.040
|
|
|
purine nucleoside monophosphate biosynthetic process
|
GO:0009127 |
3 |
0.039
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.038
|
Human |
|
ribose phosphate biosynthetic process
|
GO:0046390 |
28 |
0.038
|
|
|
cell death
|
GO:0008219 |
279 |
0.037
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.036
|
Human |
|
eye morphogenesis
|
GO:0048592 |
260 |
0.035
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.035
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
75 |
0.034
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.034
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.033
|
Human |
|
sex differentiation
|
GO:0007548 |
81 |
0.033
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.032
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.032
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.031
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.031
|
Human |
|
programmed cell death
|
GO:0012501 |
257 |
0.030
|
|
|
neuroblast proliferation
|
GO:0007405 |
74 |
0.030
|
|
|
regulation of cell proliferation
|
GO:0042127 |
163 |
0.030
|
|
|
spermatid differentiation
|
GO:0048515 |
114 |
0.029
|
|
|
innate immune response
|
GO:0045087 |
144 |
0.029
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.029
|
Human |
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.028
|
Human |
|
cellular catabolic process
|
GO:0044248 |
372 |
0.028
|
Human |
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.028
|
Human |
|
cation transport
|
GO:0006812 |
110 |
0.028
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
40 |
0.028
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.027
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
39 |
0.027
|
Human |
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
3 |
0.027
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.027
|
Human |
|
ribonucleoside monophosphate biosynthetic process
|
GO:0009156 |
3 |
0.025
|
|
|
atp biosynthetic process
|
GO:0006754 |
2 |
0.025
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.025
|
Human |
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
210 |
0.024
|
|
|
atp catabolic process
|
GO:0006200 |
38 |
0.024
|
Human |
|
glycosyl compound biosynthetic process
|
GO:1901659 |
3 |
0.024
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.024
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.022
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.022
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
143 |
0.022
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.022
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.022
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.022
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
30 |
0.021
|
|
|
immune response
|
GO:0006955 |
246 |
0.021
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.021
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.021
|
|
|
positive regulation of viral process
|
GO:0048524 |
2 |
0.021
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.021
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.020
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.019
|
Human |
|
spinal cord development
|
GO:0021510 |
1 |
0.019
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.018
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
69 |
0.018
|
|
|
response to other organism
|
GO:0051707 |
293 |
0.017
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.017
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.017
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
73 |
0.017
|
|
|
reproductive system development
|
GO:0061458 |
74 |
0.017
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.017
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
34 |
0.016
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
85 |
0.016
|
|
|
proton transport
|
GO:0015992 |
7 |
0.016
|
|
|
maintenance of location
|
GO:0051235 |
73 |
0.015
|
|
|
response to monosaccharide
|
GO:0034284 |
4 |
0.015
|
|
|
nucleoside monophosphate biosynthetic process
|
GO:0009124 |
4 |
0.015
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.015
|
|
|
immune system process
|
GO:0002376 |
347 |
0.015
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
2 |
0.015
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.015
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.014
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
143 |
0.014
|
|
|
oxoacid metabolic process
|
GO:0043436 |
103 |
0.014
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
34 |
0.014
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
237 |
0.014
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.014
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.014
|
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.014
|
|
|
germarium derived egg chamber formation
|
GO:0007293 |
101 |
0.014
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.014
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
92 |
0.013
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.013
|
|
|
circulatory system development
|
GO:0072359 |
82 |
0.013
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.013
|
|
|
regulation of nervous system development
|
GO:0051960 |
248 |
0.013
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.013
|
|
|
lipid metabolic process
|
GO:0006629 |
121 |
0.013
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
142 |
0.013
|
|
|
regulation of immune system process
|
GO:0002682 |
176 |
0.013
|
|
|
cation transmembrane transport
|
GO:0098655 |
88 |
0.013
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.012
|
Human |
|
lateral inhibition
|
GO:0046331 |
206 |
0.012
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
61 |
0.012
|
|
|
response to oxygen levels
|
GO:0070482 |
59 |
0.012
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.012
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.012
|
|
|
mitochondrion organization
|
GO:0007005 |
65 |
0.012
|
|
|
negative regulation of developmental process
|
GO:0051093 |
201 |
0.012
|
|
|
locomotory behavior
|
GO:0007626 |
176 |
0.012
|
|
|
detection of stimulus
|
GO:0051606 |
156 |
0.012
|
|
|
defense response
|
GO:0006952 |
300 |
0.012
|
|
|
regulation of developmental growth
|
GO:0048638 |
174 |
0.012
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
28 |
0.012
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.012
|
|
|
eye development
|
GO:0001654 |
323 |
0.011
|
|
|
negative regulation of nucleotide catabolic process
|
GO:0030812 |
1 |
0.011
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
3 |
0.011
|
|
|
spermatid development
|
GO:0007286 |
98 |
0.011
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
21 |
0.011
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
29 |
0.011
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.011
|
|
|
protein destabilization
|
GO:0031648 |
2 |
0.011
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.011
|
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.010
|
|
|
regulation of cell cycle checkpoint
|
GO:1901976 |
2 |
0.010
|
|
|
positive regulation of binding
|
GO:0051099 |
4 |
0.010
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
34 |
0.010
|
|
|
response to hypoxia
|
GO:0001666 |
53 |
0.010
|
|
|
regulation of viral genome replication
|
GO:0045069 |
4 |
0.010
|
|